# EDGAR Filing Document

**Accession Number:** 0001395064
**File Stem:** 0001395064-26-000179
**Filing Date:** 2026-6
**Character Count:** 1958
**Document Hash:** 8615646df8871d5b890ef96b2c06f284
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001395064-26-000179.hdr.sgml**: 20260617

**ACCESSION NUMBER**: 0001395064-26-000179

**CONFORMED SUBMISSION TYPE**: IRANNOTICE

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260617

**DATE AS OF CHANGE**: 20260617

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** TAKEDA PHARMACEUTICAL CO LTD
- **CENTRAL INDEX KEY:** 0001395064
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000

**FILING VALUES:**
- **FORM TYPE:** IRANNOTICE
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38757
- **FILM NUMBER:** 261096546

**BUSINESS ADDRESS:**
- **STREET 1:** 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU
- **CITY:** TOKYO
- **STATE:** M0
- **ZIP:** 103-8668
- **BUSINESS PHONE:** 81332782111

**MAIL ADDRESS:**
- **STREET 1:** 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU
- **CITY:** TOKYO
- **STATE:** M0
- **ZIP:** 103-8668

U.S. Securities and Exchange

Commission

100 F Street, N.E.

Washington, DC 20549

June 17, 2026

**Re: Notice of disclosure filed in Exchange Act Annual Report under Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Exchange Act**

Dear Sirs:

Pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Securities Exchange Act of 1934, as amended, notice is hereby provided that Takeda Pharmaceutical Company Limited has made disclosure pursuant to those provisions in its Annual Report on Form 20-F for the year ended March 31, 2026, which was filed with the Securities and Exchange Commission on June 17, 2026.

Sincerely,

---

| |
|:---|
| /s/ Milano Furuta |
| Milano Furuta |
| Director and Chief Financial Officer&nbsp;&nbsp;&nbsp;&nbsp; |

---

**Takeda Pharmaceutical Company Limited**&nbsp;&nbsp;&nbsp;&nbsp;<br>1-1, Nihonbashi-Honcho 2-Chome<br>Chuo-ku, Tokyo 103-8668, Japan<br>

<br>